Pbz Otc Cream
NDC Package 69993-151-01
Package Information
Pbz Otc (tripelennamine hcl 1%) cream is adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily.Children under 2 years of age: Do not use, consult a physician.Storage Information: Protect from freezing and excessive heat, store at 68°-77°F (20°-25°C). This formulation utilizes a cream delivery system. Marketed by Kingsway Pharmaceuticals Dba Nfi, Llc, this product is identified by NDC 69993-151 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 2711712 - tripelennamine HCl 1 % Topical Cream
- RxCUI: 2711712 - tripelennamine hydrochloride 10 MG/ML Topical Cream
- RxCUI: 2711712 - tripelennamine hydrochloride 1 % Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69993 - Kingsway Pharmaceuticals Dba Nfi, Llc
- 69993-151 - Pbz Otc
- 69993-151-01 - 1 TUBE in 1 CARTON / 28 g in 1 TUBE
- 69993-151 - Pbz Otc
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (69993-151). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69993-151-01 identifies a specific commercial package of 1 tube in 1 carton / 28 g in 1 tube of Pbz Otc, a human over the counter drug labeled by Kingsway Pharmaceuticals Dba Nfi, Llc. This cream is formulated for topical use and contains tripelennamine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kingsway Pharmaceuticals Dba Nfi, Llc on February 01, 2025. The current certification is valid through December 31, 2026.
How is this Kingsway Pharmaceuticals Dba Nfi, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69993015101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.